RTW Investments LP Acquires 193,300 Shares of Stryker Co. (NYSE:SYK)

RTW Investments LP increased its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 48.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 590,221 shares of the medical technology company's stock after purchasing an additional 193,300 shares during the quarter. Stryker accounts for approximately 3.2% of RTW Investments LP's holdings, making the stock its 9th biggest position. RTW Investments LP owned approximately 0.15% of Stryker worth $212,509,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SYK. Kohmann Bosshard Financial Services LLC acquired a new stake in Stryker in the fourth quarter valued at $25,000. Rakuten Securities Inc. raised its stake in shares of Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after buying an additional 68 shares during the last quarter. Centricity Wealth Management LLC acquired a new position in shares of Stryker during the 4th quarter worth $30,000. BankPlus Trust Department acquired a new position in shares of Stryker during the 4th quarter worth $33,000. Finally, Activest Wealth Management acquired a new position in shares of Stryker during the 4th quarter worth $36,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now owns 3,417,326 shares in the company, valued at $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares of the company's stock, valued at approximately $5,705,827.65. This represents a 14.16% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on SYK shares. StockNews.com downgraded Stryker from a "buy" rating to a "hold" rating in a research note on Thursday, March 6th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Roth Mkm lifted their price target on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Wells Fargo & Company lifted their price target on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 29th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $442.00 price target on shares of Stryker in a research note on Friday, March 21st. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Stryker presently has a consensus rating of "Moderate Buy" and a consensus price target of $427.05.

Stryker Trading Up 0.1%

NYSE SYK traded up $0.42 during mid-day trading on Monday, hitting $394.63. The company's stock had a trading volume of 1,072,276 shares, compared to its average volume of 1,347,466. The firm has a market capitalization of $150.63 billion, a P/E ratio of 50.85, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a 52-week low of $314.93 and a 52-week high of $406.19. The stock's fifty day simple moving average is $366.62 and its two-hundred day simple moving average is $375.61.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The company had revenue of $5.87 billion during the quarter, compared to analyst estimates of $5.68 billion. During the same quarter in the prior year, the business earned $2.50 earnings per share. The business's quarterly revenue was up 11.9% compared to the same quarter last year. Research analysts expect that Stryker Co. will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 annualized dividend and a yield of 0.85%. Stryker's dividend payout ratio is currently 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.